165 related articles for article (PubMed ID: 29920286)
1. The inhibition, reactivation and mechanism of VX-, sarin-, fluoro-VX and fluoro-sarin surrogates following their interaction with HuAChE and HuBuChE.
Chao CK; Balasubramanian N; Gerdes JM; Thompson CM
Chem Biol Interact; 2018 Aug; 291():220-227. PubMed ID: 29920286
[TBL] [Abstract][Full Text] [Related]
2. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Ashani Y; Pistinner S
Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
[TBL] [Abstract][Full Text] [Related]
3. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
[TBL] [Abstract][Full Text] [Related]
4. Nerve agent analogues that produce authentic soman, sarin, tabun, and cyclohexyl methylphosphonate-modified human butyrylcholinesterase.
Gilley C; MacDonald M; Nachon F; Schopfer LM; Zhang J; Cashman JR; Lockridge O
Chem Res Toxicol; 2009 Oct; 22(10):1680-8. PubMed ID: 19715348
[TBL] [Abstract][Full Text] [Related]
5. Novel Organophosphate Ligand O-(2-Fluoroethyl)-O-(p-Nitrophenyl)Methylphosphonate: Synthesis, Hydrolytic Stability and Analysis of the Inhibition and Reactivation of Cholinesterases.
Chao CK; Ahmed SK; Gerdes JM; Thompson CM
Chem Res Toxicol; 2016 Nov; 29(11):1810-1817. PubMed ID: 27551891
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases.
Maček Hrvat N; Kalisiak J; Šinko G; Radić Z; Sharpless KB; Taylor P; Kovarik Z
Toxicol Lett; 2020 Mar; 321():83-89. PubMed ID: 31863869
[TBL] [Abstract][Full Text] [Related]
7. Novel bifunctional hybrid small molecule scavengers for mitigating nerve agents toxicity.
Amitai G; Gez R; Raveh L; Bar-Ner N; Grauer E; Chapman S
Chem Biol Interact; 2016 Nov; 259(Pt B):187-204. PubMed ID: 27129421
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
Bartling A; Worek F; Szinicz L; Thiermann H
Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
[TBL] [Abstract][Full Text] [Related]
9. Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates.
Chambers JE; Chambers HW; Meek EC; Pringle RB
Chem Biol Interact; 2013 Mar; 203(1):135-8. PubMed ID: 23123249
[TBL] [Abstract][Full Text] [Related]
10. Novel centrally active oxime reactivators of acetylcholinesterase inhibited by surrogates of sarin and VX.
Chambers JE; Meek EC
Neurobiol Dis; 2020 Jan; 133():104487. PubMed ID: 31158460
[TBL] [Abstract][Full Text] [Related]
11. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates.
Worek F; Reiter G; Eyer P; Szinicz L
Arch Toxicol; 2002 Sep; 76(9):523-9. PubMed ID: 12242610
[TBL] [Abstract][Full Text] [Related]
12. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase.
Worek F; Aurbek N; Wetherell J; Pearce P; Mann T; Thiermann H
Toxicology; 2008 Feb; 244(1):35-41. PubMed ID: 18054823
[TBL] [Abstract][Full Text] [Related]
13. The oxime pro-2-PAM provides minimal protection against the CNS effects of the nerve agents sarin, cyclosarin, and VX in guinea pigs.
Shih TM; Guarisco JA; Myers TM; Kan RK; McDonough JH
Toxicol Mech Methods; 2011 Jan; 21(1):53-62. PubMed ID: 21117832
[TBL] [Abstract][Full Text] [Related]
14. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates.
Chambers JE; Meek EC; Chambers HW
Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX.
Chambers JE; Chambers HW; Funck KE; Meek EC; Pringle RB; Ross MK
Chem Biol Interact; 2016 Nov; 259(Pt B):154-159. PubMed ID: 27387540
[TBL] [Abstract][Full Text] [Related]
16. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for detection and identification of albumin phosphylation by organophosphorus pesticides and G- and V-type nerve agents.
John H; Breyer F; Thumfart JO; Höchstetter H; Thiermann H
Anal Bioanal Chem; 2010 Nov; 398(6):2677-91. PubMed ID: 20730528
[TBL] [Abstract][Full Text] [Related]
17. A structure-activity analysis of the variation in oxime efficacy against nerve agents.
Maxwell DM; Koplovitz I; Worek F; Sweeney RE
Toxicol Appl Pharmacol; 2008 Sep; 231(2):157-64. PubMed ID: 18508103
[TBL] [Abstract][Full Text] [Related]
18. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates.
Radić Z; Sit RK; Garcia E; Zhang L; Berend S; Kovarik Z; Amitai G; Fokin VV; Barry Sharpless K; Taylor P
Chem Biol Interact; 2013 Mar; 203(1):67-71. PubMed ID: 22975155
[TBL] [Abstract][Full Text] [Related]
20. Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents.
Koplovitz I; Harris LW; Anderson DR; Lennox WJ; Stewart JR
Fundam Appl Toxicol; 1992 Jan; 18(1):102-6. PubMed ID: 1601200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
